Preview

Russian neurological journal

Advanced search

Genetic characteristic and clinical features of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

https://doi.org/10.30629/2658-7947-2022-27-1-32-42

Abstract

Introduction. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is one of the most common genetic causes of small-vessel cerebral diseases.

Objective. The aim of our study was to examine the frequency and severity of phenotypic spectrum in patients with CADASIL, including the study of the prevalence of the NOTCH3 gene mutations in patients with suspected CADASIL.

Material and methods. Sanger sequencing of exons 2–7, 11 of NOTCH3 gene was conducted in 314 patients with suspected CADASIL (confirmed by anamnesis and magnetic resonance imaging (MRI)). Clinical and MRI data were collected and analyzed for 14 patients with CADASIL.

Results. NOTCH3 gene aberrations in exons 2–7, 11 were detected in 34 of 314 examined patients, that is 11% of all cases. The most frequent aberrations are localized in exon 4 (70.4%), exon 3 and exon 6 (8.8%) of the NOTCH3 gene. A detailed analysis of clinical and instrumental data was conducted in 14 cases of confirmed CADASIL with pathogenic mutations.

Conclusion. The age of manifestation of CADASIL in the Russian population varies significantly. Patients without a previous history of TIA/stroke may have an atypical course of the disease, including cerebellar ataxia and epilepsy. MRI pattern of the CADASIL patients of the studied cohort showed no severe damage of external capsules and temporal lobes. Spinal cord lesion are not to be excluded as a CADASIL symptom.

About the Authors

C. C. Cherebillo
Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation
Russian Federation

Saint Petersburg



V. D. Nazarov
Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation
Russian Federation

Saint Petersburg



Y. M. Kiryanov
Saint Petersburg City Mariinskaya Hospital
Russian Federation

Saint Petersburg



C. V. Lapin
Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation
Russian Federation

Saint Petersburg



A. V. Mazing
Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation
Russian Federation

Saint Petersburg



N. V. Shuleshova
Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation
Russian Federation

Saint Petersburg



G. S. Makshakov
City Center of Multiple Sclerosis and Other Autoimmune Diseases, City Clinical Hospital №31
Russian Federation

Saint Petersburg



N. A. Totolyan
Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation
Russian Federation

Saint Petersburg



Y. B. Kushnir
Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation
Russian Federation

Saint Petersburg



A. V. Cupaeva
City Center of Multiple Sclerosis and Other Autoimmune Diseases, City Clinical Hospital №31
Russian Federation

Saint Petersburg



V. D. Piven
City Center of Multiple Sclerosis and Other Autoimmune Diseases, City Clinical Hospital №31
Russian Federation

Saint Petersburg



V. L. Emanuel
Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation
Russian Federation

Saint Petersburg



References

1. llarioshkin S.N., Slominsky P.A., Shadrina M.I., Partola M.V., Kandyba D.V., Zhulev N.M. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): first description of a Russian family with the identified mutation in the Notch3 gene. Annals of Clinical and Experimental Neurology. 2008;2(2):45–50 (In Russian). https://doi.org/10.1590/0004-282X20150113

2. Bianchi S., Zicari E., Carluccio A., Di Donato I., Pescini F., Nannucci S. et al. CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients. J. Neurol. 2015;262(1):134–141. https://doi.org/10.1007/s00415-014-7533-2

3. Rutten J.W., Dauwerse H.G., Gravesteijn G., van Belzen M.J., van der Grond J., Polke J.M. et al. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL. Ann. Clin. Transl. Neurol. 2016;3(11):844–853. https://doi.org/10.1002/acn3.344

4. Bersano A., Ranieri M., Ciammola A., Cinnante C., Lanfranconi S., Dotti M. T. et al. Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant. Funct. Neurol. 2012;27(4):247–252. PMID: 23597439

5. Dichgans M., Mayer M., Uttner I., Brüning R., Müller-Höcker J., Rungger G. et al. The phenotypic spectrum of CADASIL: Clinical findings in 102 cases. Ann. Neurol. 1998;44(5):731–739. https://doi.org/10.1002/ana.410440506

6. Granild-Jensen J., Jensen U.B., Schwartz M., Hansen U.S. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy resulting in stroke in an 11-year-old male. Dev. Med. Child Neurol. 2009;51(9):754–757. https://doi.org/10.1111/j.1469-8749.2008.03241.x

7. Moroz A.A., Abramycheva N.Y., Stepanova M.S., Konovalov R.N., Timerbaeva S.L., Illarioshkin S.N. Differential diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4):75–80. (In Russian). https://doi.org/10.17116/jnevro20171174175-80

8. Rutten J.W., Van Eijsden B.J., Duering M., Jouvent E., Opherk C., Pantoni L., Federico A., Dichgans M., Markus H.S., Chabriat H., Lesnik Oberstein S.A.J. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant. Genet. Med. 2019;21(8):676–682. https://doi.org/10.1038/s41436-018-0306-z

9. Gaaib J.N., Nassief A.F., Al-Assi A.H. Simple salting-out method for genomic DNA extraction from whole Blood. Tikrit Journal of Pure Science 2011;16:1813–662. https://www.researchgate.net/publication/271385502

10. Federico A., Bianchi S., Dotti M.T. The spectrum of mutations for CADASIL diagnosis. Neurol. Sci. 2005;26(2):117–124. https://doi.org/10.1007/s10072-005-0444-3

11. Markus H.S., Martin R.J., Simpson M.A., Dong Y.B., Ali N., Crosby A.H., Powell J.F. Diagnostic strategies in CADASIL. Neurology. 2002;59(8):1134–1138. https://doi.org/10.1212/wnl.59.8.1134

12. Wang T., Sharma S. D., Fox N., Rossor M., Brown M.J., Sharma P. Description of a simple test for CADASIL disease and determination of mutation frequencies in sporadic ischaemic stroke and dementia patients. J. Neurol. Neurosurg. Psychiatry. 2000;69(5):652–4. https://doi.org/10.1136/jnnp.69.5.652

13. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202

14. Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). American Psychiatric Association. 2013. Arlington, VA: American Psychiatric Publishing: 5–25. ISBN 978-0-89042-555-8

15. Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53(4):695–9. https://doi.org/10.1111/j.1532-5415.2005.53221.x

16. Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38. https://doi.org/10.1016/S1474-4422(13)70124-8

17. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am. J. Roentgenol. 1987;149(2):351–356. https://doi.org/10.2214/ajr.149.2.351

18. Chabriat H., Joutel A., Dichgans M., Tournier-Lasserve E., Bousser M.-G. Cadasil. Lancet Neurol. 2009;8(7): 643–653. https://doi.org/10.1016/S1474-4422(09)70127-9

19. Locatelli M., Padovani A., Pezzini A. Pathophysiological Mechanisms and Potential Therapeutic Targets in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). Front Pharmacol. 2020;11:321. https://doi.org/10.3389/fphar.2020.00321

20. Park D.G., Min J.H., Sohn Shyang, Sohn Y.B., Yoon J.H. Ataxia Associated with CADASIL: a Pathology-Confirmed Case Report and Literature Review. Cerebellum. 2020;19(6):907–910. https://doi.org/10.1007/s12311-020-01173-z

21. Vedeler C., Bindoff L. A family with atypical CADASIL. J. Neurol. 2011;258(10):1888–9. https://doi.org/10.1007/s00415-011-6023-z

22. Buffon F., Porcher R., Hernandez K., Kurtz A., Pointeau S., Vahedi K., Bousser M.-G., Chabriat H. Cognitive profile in CADASIL. J. Neurol. Neurosurg. Psychiatry. 2006;77(2):175–180. https://doi.org/10.1136/jnnp.2005.068726

23. Tan Q.-C., Zhang J.-T., Cui R.-T., Xu Q.-G., Huang X.-S., Yu S.-Y. Characteristics of CADASIL in Chinese mainland patients. Neurol. India. 2014;62(3):257–61. https://doi.org/10.4103/0028-3886.136900

24. Haan J., Lesnik Oberstein S.A.J., Ferrari M.D. Epilepsy in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Cerebrovasc. Dis. 2007;24(2–3):316–7. https://doi.org/10.1159/000106518

25. Lesnik Oberstein S.A.J., Jukema J.W., Van Duinen S.G., Macfarlane P.W., van Houwelingen H.C., Breuning M.H. et al. Myocardial infarction in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Medicine (Baltimore).2003;82(4):251–6. https://doi.org/10.1097/01.md.0000085054.63483.40

26. Nelis P., Kleffner I., Burg M.C., Clemens C.R., Alnawaiseh M., Motte J. et al. OCT-Angiography reveals reduced vessel density in the deep retinal plexus of CADASIL patients. Sci. Rep. 2018;8(1):8148. https://doi.org/10.1038/s41598-018-26475-5

27. Bentley P., Wang T., Malik O., Nicholas R., Ban M., Sawcer S., Sharma P. CADASIL with cord involvement associated with a novel and atypical NOTCH3 mutation. J. Neurol. Neurosurg. Psychiatry. 2011;82(8):855–60. https://doi.org/10.1136/jnnp.2010.223297


Review

For citations:


Cherebillo C.C., Nazarov V.D., Kiryanov Y.M., Lapin C.V., Mazing A.V., Shuleshova N.V., Makshakov G.S., Totolyan N.A., Kushnir Y.B., Cupaeva A.V., Piven V.D., Emanuel V.L. Genetic characteristic and clinical features of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Russian neurological journal. 2022;27(1):32-42. https://doi.org/10.30629/2658-7947-2022-27-1-32-42

Views: 838


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2658-7947 (Print)
ISSN 2686-7192 (Online)